Shows targeted PET imaging improves melanoma diagnosis, indicating a significant advancement in detection methods.
Cu injection group showed specific tumor uptake and retention for 48 h (4.92 ± 0.74%ID/g at 48 h). The novel chelator MI-0201B2 exhibited excellent melanin targeting activity, demonstrating its potential as a PET imaging agent for melanoma diagnosis utilizing a bioorthogonal strategy.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: